title: C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
abstract: The complement activation demonstrated by vascular C4d deposition is used to diagnose antibody-mediated rejection (AMR) in renal allografts, but remains controversial in lung transplantation (LTX).
  
  
  METHODS
  C4d deposition was assessed by immunohistochemistry in 192 lung transplant biopsies from 32 patients. ELISA analysis was performed on 415 serum samples in those 32 temporally and rejection-grade matched LTX patients; 16 patients developed HLA-Ab, while the other 16 patients remained negative. The specificity of C4d staining was further compared in 18 additional LTX patients without HLA-Ab or acute cellular rejection (ACR), but in the presence of CMV-pneumonitis or reperfusion injury.
  
  
  RESULTS
  Specific subendothelial C4d deposition was seen in 5 of 16 (31%) patients with HLA-Ab and was absent in 16 patients without HLA-Ab (p<0.05). All patients with specific C4d deposition exhibited donor-specific HLA-Ab. There were 13 patients with bronchiolitis obliterans syndrome in the group of 16 HLA-Ab positive patients, versus 2/16 in ELISA-negative patients (p<0.005). One of 7 patients with CMV pneumonitis and 2 of 11 patients with reperfusion injury also showed C4d positivity (not statistically significant).
  
  
  CONCLUSIONS
  In this study, specific subendothelial C4d deposition was a marker for the involvement of HLA-Ab in lung allograft rejection. The patchy nature, low sensitivity, and specificity of C4d staining might limit clinical use in protocol biopsies. However, in patients with decreasing pulmonary function, refractory ACR and/or HLA-Ab, specific C4d deposition may serve as a marker of coexistent AMR.
authors.forename: D N
authors.initials: DN
authors.lastname: Ionescu
authors.forename: A L
authors.initials: AL
authors.lastname: Girnita
authors.forename: A
authors.initials: A
authors.lastname: Zeevi
authors.forename: R
authors.initials: R
authors.lastname: Duquesnoy
authors.forename: J
authors.initials: J
authors.lastname: Pilewski
authors.forename: B
authors.initials: B
authors.lastname: Johnson
authors.forename: S
authors.initials: S
authors.lastname: Studer
authors.forename: K R
authors.initials: KR
authors.lastname: McCurry
authors.forename: S A
authors.initials: SA
authors.lastname: Yousem
mesh_terms: D000208:Acute Disease; D015935:Complement C4b / Q000032:analysis*; D006084:Graft Rejection / Q000175:diagnosis* / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D008168:Lung / Q000276:immunology*; D016040:Lung Transplantation / Q000276:immunology*; D010446:Peptide Fragments / Q000032:analysis*
chemical_list: D006680:HLA Antigens; D007518:Isoantibodies; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d